Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Accured Expenses (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Change in Accured Expenses data on record, last reported at -$419000.0 in Q1 2013.

  • For Q1 2013, Change in Accured Expenses fell 1409.38% year-over-year to -$419000.0; the TTM value through Mar 2013 reached -$141000.0, down 194.0%, while the annual FY2025 figure was $295000.0, 1452.63% up from the prior year.
  • Change in Accured Expenses reached -$419000.0 in Q1 2013 per SNOA's latest filing, down from $349000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.3 million in Q1 2011 and bottomed at -$419000.0 in Q1 2013.
  • Average Change in Accured Expenses over 4 years is $102916.7, with a median of -$3500.0 recorded in 2010.
  • Peak YoY movement for Change in Accured Expenses: surged 1992.86% in 2011, then crashed 1409.38% in 2013.
  • A 4-year view of Change in Accured Expenses shows it stood at $58000.0 in 2010, then plummeted by 260.34% to -$93000.0 in 2011, then skyrocketed by 475.27% to $349000.0 in 2012, then crashed by 220.06% to -$419000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$419000.0 in Q1 2013, $349000.0 in Q4 2012, and -$92000.0 in Q3 2012.